BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19532104)

  • 1. Anemia and heart failure.
    Ghali JK
    Curr Opin Cardiol; 2009 Mar; 24(2):172-8. PubMed ID: 19532104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correcting anemia in heart failure: the efficacy and safety of erythropoiesis-stimulating agents.
    Lawler PR; Filion KB; Eisenberg MJ
    J Card Fail; 2010 Aug; 16(8):649-58. PubMed ID: 20670844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaemia in older people with chronic heart failure: The potential cost.
    Man-Fai Sim V; Nam MC; Riley S; Yousef Z; Hurley J; Cheung WY; O'Mahony S
    Technol Health Care; 2009; 17(5-6):377-85. PubMed ID: 20051617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoiesis-stimulating agents and heart failure.
    Lipšic E; van der Meer P; van Veldhuisen DJ
    Cardiovasc Ther; 2011 Aug; 29(4):e52-9. PubMed ID: 20973926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future directions in management of anemia in heart failure.
    Agarwal AK; Katz SD
    Heart Fail Clin; 2010 Jul; 6(3):385-95. PubMed ID: 20630412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoiesis stimulating agents (ESAs) for congestive heart failure: the red and the black.
    Robles NR; Macias JF; Herrera J
    Eur J Intern Med; 2014 Feb; 25(2):193-6. PubMed ID: 24491240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of anemia in heart failure and its effects on prognosis.
    Belziti CA
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):131-8. PubMed ID: 19210209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of erythropoiesis-stimulating agents in the treatment of anemia in patients with systolic heart failure.
    Lindquist DE; Cruz JL; Brown JN
    J Cardiovasc Pharmacol Ther; 2015 Jan; 20(1):59-65. PubMed ID: 24996902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia in chronic heart failure.
    Drakos SG; Anastasiou-Nana MI; Malliaras KG; Nanas JN
    Congest Heart Fail; 2009; 15(2):87-92. PubMed ID: 19379455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of erythropoiesis-stimulating agents in the treatment of anemia.
    Fishbane S
    Am J Manag Care; 2010 Mar; 16 Suppl Issues():S67-73. PubMed ID: 20297874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of anemia in heart failure.
    Stamos TD; Silver MA
    Curr Opin Cardiol; 2010 Mar; 25(2):148-54. PubMed ID: 19996965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the use of erythropoiesis-stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphoma.
    Katodritou E; Dimopoulos MA; Zervas K; Terpos E
    Cancer Treat Rev; 2009 Dec; 35(8):738-43. PubMed ID: 19733008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia and cardiovascular risk in the patient with kidney disease.
    Fishbane S
    Heart Fail Clin; 2008 Oct; 4(4):401-10. PubMed ID: 18760752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summaries of nursing care-related systematic reviews from the Cochrane library: erythropoiesis-stimulating agents for anemia in chronic heart failure patients.
    Barrett D
    J Cardiovasc Nurs; 2010; 25(5):381-2. PubMed ID: 20714234
    [No Abstract]   [Full Text] [Related]  

  • 15. Emerging role of anemia in heart failure.
    Mitchell JE
    Am J Cardiol; 2007 Mar; 99(6B):15D-20D. PubMed ID: 17378990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anemia in heart failure: pathophysiologic insights and treatment options.
    Terrovitis JV; Anastasiou-Nana M; Kaldara E; Drakos SG; Nanas SN; Nanas JN
    Future Cardiol; 2009 Jan; 5(1):71-81. PubMed ID: 19371205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anemia of heart failure.
    Silverberg DS; Wexler D; Palazzuoli A; Iaina A; Schwartz D
    Acta Haematol; 2009; 122(2-3):109-19. PubMed ID: 19907148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating anemia in heart failure patients: a review of erythropoiesis-stimulating agents.
    Geisler BP
    Expert Opin Biol Ther; 2010 Aug; 10(8):1209-16. PubMed ID: 20557272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia in heart failure:current evidence and challenges.
    Tang WH
    Rev Cardiovasc Med; 2007; 8(2):78-86. PubMed ID: 17603426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse consequences with use of erythropoiesis-stimulating agents in anemia prompt release of guidelines to ensure safe use and maximize benefit.
    Dharmarajan TS; Widjaja D
    Geriatrics; 2008 Jun; 63(6):13-29. PubMed ID: 18512996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.